Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
WBA
Upturn stock ratingUpturn stock rating

Walgreens Boots Alliance Inc (WBA)

Upturn stock ratingUpturn stock rating
$11.55
Last Close (24-hour delay)
Profit since last BUY3.77%
upturn advisory
Consider higher Upturn Star rating
BUY since 36 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

07/07/2025: WBA (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

14 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $12.63

1 Year Target Price $12.63

Analysts Price Target For last 52 week
$12.63 Target price
52w Low $7.98
Current$11.55
52w High $13.25

Analysis of Past Performance

Type Stock
Historic Profit -43.65%
Avg. Invested days 19
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 07/07/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 9.93B USD
Price to earnings Ratio -
1Y Target Price 12.63
Price to earnings Ratio -
1Y Target Price 12.63
Volume (30-day avg) 14
Beta 0.75
52 Weeks Range 7.98 - 13.25
Updated Date 07/7/2025
52 Weeks Range 7.98 - 13.25
Updated Date 07/7/2025
Dividends yield (FY) 8.71%
Basic EPS (TTM) -7.29

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-06-25
When Before Market
Estimate 0.3305
Actual 0.38

Profitability

Profit Margin -4.07%
Operating Margin (TTM) 0.74%

Management Effectiveness

Return on Assets (TTM) 0.83%
Return on Equity (TTM) -69.58%

Valuation

Trailing PE -
Forward PE 7.35
Enterprise Value 38131980942
Price to Sales(TTM) 0.06
Enterprise Value 38131980942
Price to Sales(TTM) 0.06
Enterprise Value to Revenue 0.25
Enterprise Value to EBITDA -22.57
Shares Outstanding 865561024
Shares Floating 716017757
Shares Outstanding 865561024
Shares Floating 716017757
Percent Insiders 17.44
Percent Institutions 61.57

ai summary icon Upturn AI SWOT

Walgreens Boots Alliance Inc

Company Overview

overview logo History and Background

Walgreens Boots Alliance (WBA) traces its roots back to 1901 when Charles Walgreen Sr. purchased the drugstore where he worked. Over the decades, Walgreens expanded across the United States. In 2014, Walgreens merged with Alliance Boots, forming Walgreens Boots Alliance, a global pharmacy-led health and well-being enterprise.

business area logo Core Business Areas

  • United States: This segment includes the Walgreens retail pharmacy operations, which provide prescription drugs, health and wellness products, and general merchandise across the US. They offer services like immunizations and health consultations.
  • International: Encompasses Boots retail pharmacy operations primarily in the UK and Thailand, plus pharmaceutical wholesale and distribution businesses in several European countries and Latin America.
  • Healthcare: This segment focuses on providing care through VillageMD and Shields Health solutions.

leadership logo Leadership and Structure

The company is led by CEO Tim Wentworth. The organizational structure includes distinct business segments managed by respective leadership teams, all reporting to the CEO and the Board of Directors.

Top Products and Market Share

overview logo Key Offerings

  • Prescription Medications: Walgreens is a major distributor of prescription drugs in the US. Market share data is difficult to pinpoint exactly due to fragmented reporting, but it's a significant portion of the overall pharmacy market. Competitors include CVS and Rite Aid.
  • Health and Wellness Products: Walgreens sells a wide range of over-the-counter medications, vitamins, supplements, and personal care items. Market share varies by product category. Competitors include Walmart, Target, and Amazon.
  • Beauty Products: Through the Boots brand, they offer beauty and skincare. Market share is variable by region and specific product line. Competitors include Sephora, Ulta Beauty, and department stores.

Market Dynamics

industry overview logo Industry Overview

The pharmacy and retail healthcare industry is undergoing significant changes, driven by increasing healthcare costs, technological advancements, and evolving consumer preferences. Telemedicine, online pharmacies, and value-based care models are reshaping the landscape.

Positioning

Walgreens Boots Alliance is a major player in the retail pharmacy and healthcare sector. Its competitive advantages include its established brand recognition, extensive retail footprint, and integrated healthcare offerings. They are expanding into primary care and specialty pharmacy.

Total Addressable Market (TAM)

The total addressable market for pharmacy services is substantial, estimated to be several hundred billion dollars globally. Walgreens is well-positioned to capture a significant share of this market with its diverse offerings and expanding healthcare services.

Upturn SWOT Analysis

Strengths

  • Extensive retail footprint
  • Strong brand recognition
  • Integrated pharmacy and healthcare services
  • Established international presence
  • Loyalty programs (e.g., myWalgreens)

Weaknesses

  • High debt levels
  • Competition from online retailers
  • Dependence on prescription drug sales
  • Challenges integrating acquired businesses
  • Declining profit margins

Opportunities

  • Expansion of healthcare services (e.g., primary care, telehealth)
  • Growth in specialty pharmacy
  • Strategic partnerships with healthcare providers
  • Leveraging data analytics to improve customer experience
  • International market expansion

Threats

  • Increased competition from online pharmacies
  • Reimbursement pressures from pharmacy benefit managers (PBMs)
  • Regulatory changes affecting the pharmacy industry
  • Economic downturn impacting consumer spending
  • Labor shortages

Competitors and Market Share

competitor logo Key Competitors

  • CVS (CVS)
  • RITE (RAD)
  • AMZN (AMZN)

Competitive Landscape

Walgreens competes with CVS in the retail pharmacy market, with Amazon entering the space through online pharmacy. Walgreens is focusing on healthcare services as a differentiator.

Major Acquisitions

Shields Health Solutions

  • Year: 2022
  • Acquisition Price (USD millions): 1370
  • Strategic Rationale: Strengthened Walgreens' specialty pharmacy capabilities by acquiring the remaining equity interests in Shields Health Solutions, a specialty pharmacy accelerator for hospitals.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been relatively slow in recent years, with challenges in the retail pharmacy sector.

Future Projections: Future growth projections are moderate, contingent on the success of its healthcare services expansion and cost-cutting initiatives. Analyst estimates vary.

Recent Initiatives: Recent strategic initiatives include investments in VillageMD, Shields Health, and the launch of new healthcare service offerings. Sale of Boots UK is planned but the deal has been terminated.

Summary

Walgreens Boots Alliance is facing challenges in the evolving pharmacy and healthcare market, evident in its recent performance and debt. Its strengths lie in its retail footprint and integrated services, but it must navigate increasing competition and reimbursement pressures. Their future depends on the success of their strategic healthcare ventures. Currently, the company is weak, but it's pushing to restructure the business; therefore, it needs to focus on improving its financial health.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings
  • Market Research Reports
  • Analyst Estimates
  • Public News Articles
  • SEC Filings (10-K, 10-Q)

Disclaimers:

This analysis is for informational purposes only and should not be considered investment advice. Financial data and market conditions are subject to change. Consult with a qualified financial advisor before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Walgreens Boots Alliance Inc

Exchange NASDAQ
Headquaters Deerfield, IL, United States
IPO Launch date 1985-07-01
CEO & Director Mr. Timothy C. Wentworth
Sector Healthcare
Industry Pharmaceutical Retailers
Full time employees 193000
Full time employees 193000

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.